Companies: 10,638     total market cap: โ‚ฌ116.357 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Sangamo Therapeutics
SGMO
#8725
Rank
โ‚ฌ0.14 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
0,43ย โ‚ฌ
Share price
-6.45%
Change (1 day)
-77.61%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech๐Ÿงฌ Genomics๐Ÿงฌ Gene therapy
Categories

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ25.43 Million

According to Sangamo Therapeutics 's latest financial reports the company has โ‚ฌ25.43 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ40.28 M-45.03%
2023-12-31โ‚ฌ73.27 M-71.69%
2022-12-31โ‚ฌ0.25 B-22.16%
2021-12-31โ‚ฌ0.33 B-36.24%
2020-12-31โ‚ฌ0.52 B61.17%
2019-12-31โ‚ฌ0.32 B-7.49%
2018-12-31โ‚ฌ0.34 B72.49%
2017-12-31โ‚ฌ0.20 B49.64%
2016-12-31โ‚ฌ0.13 B-29.11%
2015-12-31โ‚ฌ0.19 B29.9%
2014-12-31โ‚ฌ0.14 B118.95%
2013-12-31โ‚ฌ67.2 M39.9%
2012-12-31โ‚ฌ48.04 M-25.84%
2011-12-31โ‚ฌ64.78 M42.94%
2010-12-31โ‚ฌ45.32 M-23.55%
2009-12-31โ‚ฌ59.28 M27.84%
2008-12-31โ‚ฌ46.37 M-16.5%
2007-12-31โ‚ฌ55.53 M35.9%
2006-12-31โ‚ฌ40.86 M3.09%
2005-12-31โ‚ฌ39.63 M61.67%
2004-12-31โ‚ฌ24.51 M-29.61%
2003-12-31โ‚ฌ34.83 M-30.17%
2002-12-31โ‚ฌ49.88 M-28.48%
2001-12-31โ‚ฌ69.74 M3.45%
2000-12-31โ‚ฌ67.41 M792.62%
1999-12-31โ‚ฌ7.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
โ‚ฌ6.31 B 24,714.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ2.34 B 9,099.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.11 B 31,791.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ3.40 B 13,272.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ3.95 B 15,462.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 62,575.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.26 B 4,890.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ15.64 B 61,400.54%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com